स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
macropen 35 mg/ml zrnca za peroralno suspenzijo
krka, d.d., novo mesto - miokamicin - zrnca za peroralno suspenzijo - miokamicin 35 mg / 1 ml - miokamicin
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
macropen 400 mg filmsko obložene tablete
krka, d.d., novo mesto - midekamicin - filmsko obložena tableta - midekamicin 400 mg / 1 tableta - midekamicin
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastična sredstva - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle cell - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
macrotec 2 mg komplet za pripravo radiofarmaka
komplet za pripravo radiofarmaka - [99mtc]tehnecij (makroagregati)
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
provenge
dendreon uk ltd - avtologni mononuklearnih celic periferne krvi, vključno z najmanj 50 milijonov avtologna cd54 + celice activated s prostate kisline fosfataze makrofagov granulocitne kolonije stimulirajoči faktor - prostatične neoplazme - drugi imunostimulanti - za zdravljenje asimptomatskega ali minimalno simptomatskega metastatskega (nestardalnega) kastratnega odpornega raka na prostati pri odraslih moških, pri katerem kemoterapija še ni klinično indicirana.
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
